1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1.Drivers
3.2.2.Restraints
3.2.3.Opportunities
3.2.4.Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for the United States Computational Biology
Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in the United States Computational Biology Market
4. United States Computational
Biology Market by Application
4.1. Human Body Simulation Software
4.2. Preclinical Drug Development
4.3. Cellular & Biological Simulation
4.4. Clinical Trials
4.5. Drug Discovery
4.6. Disease Modelling
5. United States Computational
Biology Market by Service
5.1. In-house
5.2. Contract
6. United States Computational
Biology Market by End User
6.1. Academics
6.2. Commercial
7. Company Profiles
7.1. Company 1
7.2. Company 2
7.3. Company 3
7.4. Company 4
7.5. Company 5
1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1.Drivers
3.2.2.Restraints
3.2.3.Opportunities
3.2.4.Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for the United States Computational Biology
Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in the United States Computational Biology Market
4. United States Computational
Biology Market by Application
4.1. Human Body Simulation Software
4.2. Preclinical Drug Development
4.3. Cellular & Biological Simulation
4.4. Clinical Trials
4.5. Drug Discovery
4.6. Disease Modelling
5. United States Computational
Biology Market by Service
5.1. In-house
5.2. Contract
6. United States Computational
Biology Market by End User
6.1. Academics
6.2. Commercial
7. Company Profiles
7.1. Company 1
7.2. Company 2
7.3. Company 3
7.4. Company 4
7.5. Company 5